Takeda's buying spree continues with CNS splurge
November 06 2012
Takeda is plunking down $140 million for Envoy Therapeutics and its CNS tech
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.